Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that ...

Masimo stock surged Wednesday on its upbeat earnings and 2025 outlook, though one analyst cautioned cost reductions could ...

Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A ...

Masimo says strategic realignment efforts near the end of last year increased the digital health pioneer's earnings power.

Masimo (NASDAQ:MASI – Get Free Report) had its price objective upped by equities researchers at Piper Sandler from $210.00 to $215.00 in a report released on Wednesday,Benzinga reports. The brokerage ...

Wells Fargo raised the firm’s price target on Masimo (MASI) to $205 from $193 and keeps an Overweight rating on the shares. The firm is ...

Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare ...

Masimo Corp (MASI) reports robust financial performance with a 9% revenue increase, while navigating strategic realignment ...

Masimo Corporation’s MASI share price has surged by 12.35%, which has investors questioning if this is right time to sell.

Piper Sandler analyst Jason Bednar raised the firm’s price target on Masimo (MASI) to $215 from $210 and keeps an Overweight rating on the ...

Sigma Planning Corp lifted its stake in Masimo Co. (NASDAQ:MASI – Free Report) by 21.7% during the fourth quarter, Holdings ...

Medtech companies have their eye on the growing hospital-at-home market, which is driven largely by the rising elderly ...